Preparation method and application of high-activity solid-state fermented ganoderma lucidum compound for repairing hepatocyte function
By employing a three-stage compound fermentation system and specific post-processing techniques, the problem of low synthesis efficiency of Ganoderma lucidum polysaccharides and triterpenoids was solved, enabling the preparation of a highly active Ganoderma lucidum complex that repairs liver cell function. This complex can be applied to hepatoprotective drugs, functional foods, and hepatoprotective cosmetics, exhibiting significant bioactivity and economic benefits.
Patent Information
- Application Number
- CN202511983739.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-12-26
- Publication Date
- 2026-03-20
AI Technical Summary
Existing solid-state fermentation technology for the synthesis of Ganoderma lucidum polysaccharides and triterpenoids suffers from insufficient synergistic enzymatic hydrolysis and complementary metabolism among multiple strains, resulting in low enhancement of active ingredients and limited synthesis efficiency, failing to meet the demand for high-purity and high-activity raw materials.
A three-stage compound fermentation system is adopted, including enzymatic pretreatment, probiotic-yeast synergistic prefermentation, and Ganoderma lucidum directional co-fermentation. Combined with a specific matrix formula and post-processing technology, the active ingredients are enriched through enzymatic degradation of macromolecules, synergistic action of probiotics and yeast, and directional fermentation of Ganoderma lucidum.
The product significantly increased the content of Ganoderma lucidum polysaccharides by ≥2.83 times and the content of triterpenoids by ≥1.55 times. In models such as acute liver injury and alcoholic liver injury, the product achieved a decrease of ALT and AST by ≥85%, and reduced the overall cost by about 42%, showing good prospects for industrialization.